{"transactions":[{"id":706954,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":29777,"kind":"person","name":"McCauley Thomas","position":1,"cik":"0001858760","reported_name":"McCauley Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:35:58.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/4 of the total award on July 15, 2027, and as to 1/48 of the total award monthly thereafter, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":225000,"derivative":{"exercise_price":29.91,"expiration_date":"2036-07-14","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001858760-26-000008","document":"form4-07172026_080754.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858760/000185876026000008/form4-07172026_080754.xml","form_type":"4"}},{"id":1651804,"issuer":{"id":83618,"kind":"organization","name":"Omega Therapeutics, Inc.","symbol":"OMGA"},"owners":[{"id":29777,"kind":"person","name":"McCauley Thomas","position":1,"cik":"0001858760","reported_name":"McCauley Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-09T22:14:52.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in three equal installments on each of October 7, 2024, June 7, 2025 and February 7, 2026, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":75000,"derivative":{"exercise_price":3.59,"expiration_date":"2034-02-06","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000950170-24-013378","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1858760/000095017024013378/ownership.xml","form_type":"4"}},{"id":1651803,"issuer":{"id":83618,"kind":"organization","name":"Omega Therapeutics, Inc.","symbol":"OMGA"},"owners":[{"id":29777,"kind":"person","name":"McCauley Thomas","position":1,"cik":"0001858760","reported_name":"McCauley Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-09T22:14:52.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable with respect to 25% of the underlying shares on February 7, 2025 and in twelve (12) equal quarterly installments thereafter such that the option will become fully vested and exercisable on February 7, 2028, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":125000,"derivative":{"exercise_price":3.59,"expiration_date":"2034-02-06","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950170-24-013378","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858760/000095017024013378/ownership.xml","form_type":"4"}},{"id":1979963,"issuer":{"id":83618,"kind":"organization","name":"Omega Therapeutics, Inc.","symbol":"OMGA"},"owners":[{"id":29777,"kind":"person","name":"McCauley Thomas","position":1,"cik":"0001858760","reported_name":"McCauley Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option (Right to Buy)","published_at":"2023-03-02T21:05:14.000Z","date":"2023-02-28","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable with respect to 25% of the underlying shares on February 28, 2024 and in equal quarterly installments thereafter such that the option will become fully vested and exercisable on February 28, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":55000,"derivative":{"exercise_price":6.46,"expiration_date":"2033-02-27","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0000899243-23-006725","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858760/000089924323006725/doc4.xml","form_type":"4"}},{"id":2130448,"issuer":{"id":83618,"kind":"organization","name":"Omega Therapeutics, Inc.","symbol":"OMGA"},"owners":[{"id":29777,"kind":"person","name":"McCauley Thomas","position":1,"cik":"0001858760","reported_name":"McCauley Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option (Right to Buy)","published_at":"2022-10-28T22:40:34.000Z","date":"2022-10-27","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable as to 25% of the underlying shares on October 27, 2023 and as to 6.25% of the underlying shares upon the Reporting Person's completion of each three full months of continued service to the Issuer thereafter, such that the option will be fully vested and exercisable on October 27, 2026."}],"balance_after":55000,"derivative":{"exercise_price":5.27,"expiration_date":"2032-10-26","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0000899243-22-034470","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858760/000089924322034470/doc4.xml","form_type":"4"}},{"id":2337901,"issuer":{"id":83618,"kind":"organization","name":"Omega Therapeutics, Inc.","symbol":"OMGA"},"owners":[{"id":29777,"kind":"person","name":"McCauley Thomas","position":1,"cik":"0001858760","reported_name":"McCauley Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option (Right to Buy)","published_at":"2022-03-11T21:05:29.000Z","date":"2022-03-09","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable with respect to 25% of the underlying shares on March 9, 2023 and in equal quarterly installments thereafter such that the option will become fully vested and exercisable on March 9, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":110000,"derivative":{"exercise_price":10.34,"expiration_date":"2032-03-08","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0000899243-22-010692","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858760/000089924322010692/doc4.xml","form_type":"4"}}]}